Moderna Expects Approximately $4 Billion In Cash Costs In 2027

By Reuters News

- Moderna, Inc. MRNA.O:

  • MODERNA: EXPECTS APPROXIMATELY $4 BILLION IN CASH COSTS IN 2027 - WEBSITE

  • MODERNA: ANTICIPATES ENDING 2026 WITH ABOUT $9 BILLION IN TOTAL LIQUIDITY, INCLUDING CASH, INVESTMENTS AND UNDRAWN BORROWING CAPACITY

  • MODERNA: EXPECTS ANNUAL CASH COSTS OF ABOUT $4 BILLION TO $4.5 BILLION FROM 2027 THROUGH 2030

  • MODERNA : EXTENDS MATURITY OF $1.5 BILLION ARES CREDIT FACILITY TO 2031

  • MODERNA: FOLLOWING U.S. & CANADIAN APPROVALS OF MFLUSIVA IN 2026, CO PREPARING FOR BROADER COMMERCIAL LAUNCH DURING THE 2027-2028 RESPIRATORY SEASON

Further company coverage: MRNA.O

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.